EA5163/S1709 INSIGNA: A Randomized, Phase III Study of Firstline Immunotherapy alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non¿Small Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature

  • Bernicker, Eric H. (CoI)
  • Darcourt, Jorge (CoI)
  • Zhang, Jun (CoI)

Project: Non Profit

Project Details

StatusActive
Effective start/end date2/28/19 → 2/27/44